Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis
- PMID: 14562004
- PMCID: PMC2394349
- DOI: 10.1038/sj.bjc.6601286
Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis
Abstract
Tumour angiogenesis and cellular pH regulation, mainly represented by Na(+)/H(+) antiporter exchange, have been heretofore considered unrelated subfields of cancer research. In this short review, the available experimental evidence relating these areas of modern cancer research is introduced. This perspective also helps to design a new approach that facilitates the opening and development of novel research lines oriented towards a rational incorporation of anticancer drugs into more selective and less toxic therapeutic protocols. The final aim of these efforts is to control cancer progression and dissemination through the control of tumour angiogenesis. Finally, different antiangiogenic drugs that can already be clinically used to this effect are briefly presented.
References
-
- Civitelli R, Teitelbaum SL, Hruska KA, Lacey DL (1989) IL-1 activates the Na+/H+ antiport in a murine T cell. J Immunol 143: 4000–4008 - PubMed
-
- Clark JW, Chabner BA (1995) Suramin and prostate cancer: where do we go from here? J Clin Oncol 13: 2155–2157 - PubMed
-
- DiGiammarino EL, Lee AS, Cadwell C, Zhang W, Bothner B, Ribeiro RC, Zambetti G, Kriwacki RW (2002) A novel mechanism of tumourigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol 9: 12–16 - PubMed
-
- Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C (2001) Hepatocyte growth factor/scatter factor-induced activation of MEK and P13K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 61: 5911–5918 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
